Profit Investment Management, LLC - VANDA PHARMACEUTICALS INC ownership

VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 187 filers reported holding VANDA PHARMACEUTICALS INC in Q2 2023. The put-call ratio across all filers is 1.50 and the average weighting 0.0%.

Quarter-by-quarter ownership
Profit Investment Management, LLC ownership history of VANDA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$1,412,627
-34.8%
326,997
-0.5%
1.00%
-29.0%
Q2 2023$2,165,922
-4.2%
328,668
-1.3%
1.41%
-5.7%
Q1 2023$2,260,140
-8.7%
332,863
-0.6%
1.49%
-14.2%
Q4 2022$2,475,310
-25.2%
334,9540.0%1.74%
-31.3%
Q3 2022$3,309,000
+7.7%
334,954
+18.8%
2.53%
+12.3%
Q2 2022$3,071,000
-3.7%
281,8900.0%2.26%
+14.5%
Q1 2022$3,190,000
-14.6%
281,890
+18.4%
1.97%
-16.1%
Q4 2021$3,735,000
+178.9%
238,060
+204.6%
2.35%
+152.3%
Q3 2021$1,339,000
-75.7%
78,154
-69.5%
0.93%
-68.1%
Q2 2021$5,519,000
+43.2%
256,5460.0%2.92%
+33.0%
Q1 2021$3,853,000
+12.0%
256,546
-2.0%
2.19%
-0.5%
Q4 2020$3,441,000
+36.1%
261,8910.0%2.21%
+41.1%
Q3 2020$2,529,000
+15.7%
261,891
+37.1%
1.56%
+2.4%
Q2 2020$2,185,000
+100.5%
190,990
+81.5%
1.53%
+49.6%
Q1 2020$1,090,000105,2341.02%
Other shareholders
VANDA PHARMACEUTICALS INC shareholders Q2 2023
NameSharesValueWeighting ↓
ARMISTICE CAPITAL, LLC 1,532,000$27,423,0003.23%
Stonepine Capital Management, LLC 300,000$5,370,0003.16%
Palo Alto Investors LP 4,155,670$74,386,0003.13%
GREAT POINT PARTNERS LLC 497,531$8,906,0001.73%
Avoro Capital Advisors LLC 988,270$17,690,0001.37%
UNIVERSITY OF NOTRE DAME DU LAC 157,781$2,824,0000.79%
Birchview Capital, LP 68,000$1,217,0000.63%
Cheyne Capital Management (UK) LLP 74,000$1,323,0000.48%
BOGLE INVESTMENT MANAGEMENT L P /DE/ 352,604$6,311,0000.43%
361 CAPITAL LLC 119,554$2,140,0000.41%
View complete list of VANDA PHARMACEUTICALS INC shareholders